It affects more than 40% of adults in the U.S., disproportionately impacting low-income communities and communities of color, those who already face barriers to care and stigma in the healthcare system
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context for your PCP's prescribing discussion by revealing predispositions in GLP-1 receptor, GIP receptor, and metabolic efficiency pathways
They are prepared using active pharmaceutical ingredients under the direction of a prescribing clinician
Semaglutide belongs to a broader category of GLP research materials that also includes dual agonist research peptides, triple agonist research peptides, and non-peptide GLP receptor research compounds
Expected timeline: Increased GPx activity within 2-4 weeks
Dahl WJ, Hung WL, Ford AL, et al